Cite
MLA Citation
Maho Nagasawa et al.. “171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A185. http://access.bl.uk/ark:/81055/vdc_100144710219.0x00000a